For years, researchers have studied circadian disruption one variable at a time. Night owls get more disease. Short sleepers have higher mortality. People with irregular schedules face metabolic trouble. Each finding has been solid, but partial. Imagine diagnosing engine trouble by listening only to one cylinder.
A team led by scientists at the Medical University of Vienna and the Broad Institute has now tried something different. Instead of asking how any single circadian trait maps onto health, they built a composite measure they call the Circadian Imbalance Index, or CII. It is a simple 0 to 5 score that combines five seemingly disparate markers: a tendency toward eveningness, sleeping either too little or too long, high neuroticism, atypical caffeine consumption, and low vitamin D levels. The result, published July 21 in EBioMedicine, is one of the largest genetic analyses of systemic circadian disruption ever conducted.
What they found
The researchers ran a genome-wide association study on 312,935 participants from the UK Biobank, then replicated their top findings in an independent cohort from the Nurses’ Health Study II. The analysis identified 27 independent genetic loci linked to the CII, mapping to 72 genes. Among the genes highlighted were CALCA, which encodes a neuropeptide involved in pain signaling and vascular regulation; DHCR7, a vitamin D synthesis gene; KDM5A, involved in chromatin regulation; HAL, a histidine metabolism gene; and CRX, a photoreceptor development gene.
Perhaps the most striking result was that five of the mapped genes appeared only in the composite CII analysis, not in analyses of any of its five individual components. Those genes (EPHB1, SERPING1, C12orf74, PLEKHG7, and EEA1) were invisible when researchers looked at chronotype or sleep duration alone. This suggests that the CII captures a biological signal that is more than the sum of its parts, something that conventional single-trait analyses miss entirely.
The logic of a composite score
Composite risk scores are standard in cardiology. The Framingham Risk Score, for example, combines age, cholesterol, blood pressure, and smoking history into a single number that predicts heart attack risk better than any of those factors individually. The researchers behind the CII argue that circadian health deserves the same treatment.
The five components were not chosen arbitrarily. Evening chronotype is a well-documented risk factor for metabolic and psychiatric disease. Both short and long sleep duration are associated with increased mortality. Neuroticism, a personality trait marked by emotional instability, is linked to stress hormone dysregulation and poor sleep. Atypical caffeine intake (consumption far above or below population norms) can reflect attempts to self-medicate a misaligned circadian system. And low vitamin D has been tied to seasonal affective disorder, immune dysfunction, and sleep quality.
Each of these alone is a noisy signal. Together, the authors reasoned, they might converge on something more fundamental: a person’s overall degree of circadian misalignment.
Polygenic risk and the wider phenome
The team built a polygenic score for the CII and ran a phenome-wide association study across thousands of health outcomes in the UK Biobank. Higher genetic predisposition toward circadian imbalance was associated with a broad range of metabolic conditions, including elevated body mass index, type 2 diabetes, and coronary artery disease. Psychiatric signals also emerged: the CII polygenic score correlated with insomnia, mood swings, and neuroticism measures. Genetic correlation analyses confirmed significant overlap between the CII and insomnia, mood instability, BMI, type 2 diabetes, coronary artery disease, and myocardial infarction.
These findings are correlational, not causal, and the researchers are careful about that distinction. To test directionality, they used Mendelian randomization, a method that leverages the random allocation of genes at conception to mimic a randomized trial. The MR analysis provided suggestive evidence that mood swings and coronary artery disease may influence the CII score, rather than the other way around. This reverse directionality is worth pausing over: it implies that emotional and cardiovascular problems may themselves drive circadian disruption, not simply result from it.
Limitations
The study has important caveats. The UK Biobank is predominantly white and healthier than the general population, which limits generalizability. The CII itself is a relatively coarse instrument: a 0 to 5 integer score built from self-reported survey data and a single blood biomarker. It captures a snapshot, not a lifetime of circadian patterns. The Nurses’ Health Study II replication cohort is all female, so sex-specific effects could not be fully assessed. And while Mendelian randomization can suggest causal direction, it relies on strong assumptions about genetic instruments that may not always hold.
The authors also note that the CII is not a clinical tool yet. It is a research construct designed to test whether combining multiple circadian-related traits in a single score yields better genetic discovery. The early evidence suggests the answer is yes.
Why it matters
Circadian disruption is implicated in nearly every major chronic disease, from obesity and diabetes to depression and cancer. But the field has struggled to move past the basic observation that “night shift work is bad for you.” Part of the problem is measurement: circadian rhythm involves sleep timing, duration, quality, hormonal cycles, light exposure, and behavioral feedback loops. No single test captures all of that.
The CII offers a proof of concept that a simple, inexpensive composite score can uncover genetic architecture that individual traits cannot. The five newly identified genes that appeared only in the composite analysis suggest that there are biological pathways driving system-level circadian disruption that no single-trait study would ever find. If replicated and refined, this kind of approach could eventually help identify individuals at high risk for circadian-related disease before symptoms appear, and guide interventions such as light therapy, chronobiotic drugs, and behavioral scheduling targeted to their genetic profile.
Bottom line
A large-scale genetic analysis introduces a composite Circadian Imbalance Index that reveals 27 genetic loci linked to systemic circadian disruption, including five genes that single-trait analyses miss. The findings reinforce the idea that circadian health is a systems-level problem, not a collection of isolated habits, and that composite scores may uncover biological signals invisible to traditional approaches.
_Source: Zebrowska, M. et al. “Genetic architecture of a Circadian Imbalance Index: genome-wide association, phenome-wide association, and Mendelian randomization analyses.” EBioMedicine, 2026. DOI: 10.1016/j.ebiom.2026.106380. PMID: 42481375._